Biotech and pharmaceutical executive search firm, Berke Executive Search, is devoted to keeping their clients and audience informed on updates and trends in the healthcare industry. Recently, they took a look at a study conducted by the American Cancer Society on predictions for 2016 in terms on number of new cases of cancer, which types of cancer will be most prevalent, and fatality rates. While rates of cancer are increasing overall, the fatality rate is decreasing as treatments become more effective and early screening tests more prevalent and accurate. Lung, colon, prostate and breast cancer will make up more than half of all new cancer cases in the United States in the year 2016. To learn more about Berke Executive Search, a top pharmaceutical executive search firm, call 267-483-8951 or visit www.berkesearch.com.
